Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis

• Hanna M. Vesterinen ,

  Contributed equally to this work with: Hanna M. Vesterinen, Peter Connick

  Affiliation Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Peter Connick ,

  Contributed equally to this work with: Hanna M. Vesterinen, Peter Connick

  Affiliation The Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Cadi M. J. Irvine,

  Affiliation Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Emily S. Sena,

  Affiliation Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Kieren J. Egan,

  Affiliation Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Gary G. Carmichael,

  Affiliation Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Afiyah Tariq,

  Affiliation Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Sue Pavitt,

  Affiliation Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom

  ⨯
• Jeremy Chataway,

  Affiliation National Hospital for Neurology and Neurosurgery, London, United Kingdom

  ⨯
• Malcolm R. Macleod ,

  * E-mail: malcolm.macleod@ed.ac.uk (MRM); siddharthan.chandran@ed.ac.uk (SC)

  Affiliation Department of Clinical Neurosciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Siddharthan Chandran

  * E-mail: malcolm.macleod@ed.ac.uk (MRM); siddharthan.chandran@ed.ac.uk (SC)

  Affiliation The Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom

  ⨯